首页|基于家系全外显子组测序技术鉴定男性不育致病突变

基于家系全外显子组测序技术鉴定男性不育致病突变

扫码查看
目的:通过全外显子组测序(Whole Exome Sequencing,WES)技术鉴定导致男性不育的遗传因素.方法:收集患者临床表型信息,对患者和家系成员的血液样本进行全外显子组测序,通过纯合区段分析、人群频率和有害性预测进行遗传筛选,鉴定可能的致病突变,并通过物种间序列保守性和蛋白结构预测等分析判断突变的致病性.结果:WES测序结果显示端粒重复结合束形成蛋白 2(Telomere Repeat Binding Bouquet Formation Protein 2,TERB2)基因携带的纯合错义突变(TERB2:p.95 Lys>Asn)为潜在致病突变,该突变导致其与TERB1 的互作丧失,减数分裂停滞.结论:本研究通过WES技术,成功鉴定出TERB2 基因的错义突变为无精子症患者的致病突变,表明WES技术可应用于男性不育遗传诊断,TERB2 基因可作为诊断靶点.
Identification of Male Infertility Pathogenic Mutations Based on Family Whole Exome Sequencing Data
Objective:To identify the genetic factors causing male infertility by whole exome sequencing(WES).Methods:Clinical phenotype information of patients is collected,and blood samples of patients and family members are sequenced.Genetic screening is performed by homozygous segment analysis,population frequency and harmfulness prediction to identify possible pathogenic mutations,and the pathogenicity of mutations is determined by analysis of interspecies sequence conservation and protein structure prediction.Results:WES sequencing results show that the homozygous missense mutation(TERB2:p.95 Lys>Asn)carried by telomere repeat binding bouquet formation protein 2(TERB2)gene is a potential pathogenic mutation,which led to the loss of its interaction with TERB1 and meiosis arrest.Conclusion:In this study,the missense mutation of TERB2 gene is successfully identified as a pathogenic mutation in patients with azoospermia through WES technology,indicating that WES technology can be applied to the genetic diagnosis of male infertility,and TERB2 gene can be used as a diagnostic target.

whole exome sequencingmale infertilitygenetic screening

杨可心

展开 >

徐州医科大学,江苏 徐州 221000

全外显子组测序 男性不育 遗传筛选

2024

生物化工

生物化工

ISSN:
年,卷(期):2024.10(5)